711 reports of this reaction
2.3% of all ROPINIROLE reports
#6 most reported adverse reaction
HALLUCINATION is the #6 most commonly reported adverse reaction for ROPINIROLE, manufactured by Accord Healthcare Inc.. There are 711 FDA adverse event reports linking ROPINIROLE to HALLUCINATION. This represents approximately 2.3% of all 31,217 adverse event reports for this drug.
Patients taking ROPINIROLE who experience hallucination should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HALLUCINATION is a less commonly reported adverse event for ROPINIROLE, but still significant enough to appear in the safety profile.
In addition to hallucination, the following adverse reactions have been reported for ROPINIROLE:
The following drugs have also been linked to hallucination in FDA adverse event reports:
HALLUCINATION has been reported as an adverse event in 711 FDA reports for ROPINIROLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HALLUCINATION accounts for approximately 2.3% of all adverse event reports for ROPINIROLE, making it a notable side effect.
If you experience hallucination while taking ROPINIROLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.